This page is not available in the language that has been selected and will appear in English.
This page is not available in the language that has been selected.
Halaman ini tidak tersedia dalam bahasa yang dipilih.
Trang này không có sẵn bằng ngôn ngữ đã chọn.
此页面不提供所选语言的版本。
07 3737 4500
This guide helps you understand your diagnosis, explore care options, and support yourself and others during treatment.
We cover essential terminology including treatment terms, medical procedures, common side effects, and more.
Your options for treatment may be varied or few, so our guide has endeavoured to offer an extensive run-down of options.
Find a clinical trial that may suit you and your cancer diagnosis
SUNRAY-01 / J3M-MC-JZQB
Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Locations Wesley
Diagnosis Lung cancer
TRACIE / CO-AU-979-6695
TRodelvy use in AdvanCed TrIple Negative BrEast Cancer in Australia
Locations Townsville, Hobart, Adelaide
Diagnosis Breast cancer
ZN-c3-005
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (DENALI)
Locations Chermside
Diagnosis Ovarian cancer
SB221
Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer
Locations Adelaide
SSGJ-709-101
A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors
Diagnosis Advanced solid tumours
SUNRAY-02 / J3M-MC-JZQH
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Locations Adelaide, Wesley